![Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics: Molecular Therapy Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics: Molecular Therapy](https://www.cell.com/cms/asset/c41bca49-d2b1-4392-85d7-c5ceafaa0f2e/fx1.jpg)
Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics: Molecular Therapy
![Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study - The Lancet Infectious Diseases Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/2048237137/2058284958/gr1.gif)
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study - The Lancet Infectious Diseases
![From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices | ACS Nano From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.0c06688/asset/images/large/nn0c06688_0017.jpeg)
From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices | ACS Nano
![Ebola vaccines trigger durable responses in African adults and children | Gavi, the Vaccine Alliance Ebola vaccines trigger durable responses in African adults and children | Gavi, the Vaccine Alliance](https://www.gavi.org/sites/default/files/vaccineswork/2022/Header/RS28782-DRC-Ebola-1-11_h1.jpg)